Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul M Kaye

Showing results (51-60 of 136) with videos related to

Pageof 14
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|July 14, 2010
Stromal cell-derived CXCL12 and CCL8 cooperate to support increased development of regulatory dendritic cells following Leishmania infectionAnh Thu Nguyen Hoang, Hao Liu, Julius Juaréz, et al.
Trends in Parasitology|March 2, 2026
Breaking the deadlock in antigen discovery for Leishmania vaccinesWim Adriaensen, Nicky de Vrij, Thao-Thy Pham, et al.
Frontiers in Immunology|January 30, 2018
Immunomodulatory Therapy of Visceral Leishmaniasis in Human Immunodeficiency Virus-Coinfected PatientsWim Adriaensen, Thomas P C Dorlo, Guido Vanham, et al.
Frontiers in Immunology|September 3, 2019
IL-4 Mediated Resistance of BALB/c Mice to Visceral Leishmaniasis Is Independent of IL-4Rα Signaling via T CellsEmma McFarlane, Thabang Mokgethi, Paul M Kaye, et al.
The Lancet. Respiratory Medicine|December 6, 2021
Post-mortem lung tissue: the fossil record of the pathophysiology and immunopathology of severe COVID-19Luke Milross, Joaquim Majo, Nigel Cooper, et al.
Archives of Toxicology|December 22, 2016
In vivo imaging of systemic transport and elimination of xenobiotics and endogenous molecules in miceRaymond Reif, Ahmed Ghallab, Lynette Beattie, et al.
Parasites & Vectors|January 10, 2020
Leishmania braziliensis prostaglandin F<sub>2α</sub> synthase impacts host infectionEliza Vanessa Carneiro Alves-Ferreira, Tiago Rodrigues Ferreira, Pegine Walrad, et al.
Plos Neglected Tropical Diseases|July 3, 2020
The potential impact of human visceral leishmaniasis vaccines on population incidenceEpke A Le Rutte, Luc E Coffeng, Stefano Malvolti, et al.
Vaccine|November 11, 2023
Vaccine value profile for leishmaniasisPaul M Kaye, Greg Matlashewski, Sakshi Mohan, et al.
The American Journal of Pathology|December 8, 2004
Distinct roles for lymphotoxin-alpha and tumor necrosis factor in the control of Leishmania donovani infectionChristian R Engwerda, Manabu Ato, Simona Stäger, et al.
Pageof 14

Showing results (51-60 of 136) with videos related to

Sort By:
Pageof 14
Journal of Immunology (Baltimore, Md. : 1950)|July 14, 2010
Stromal cell-derived CXCL12 and CCL8 cooperate to support increased development of regulatory dendritic cells following Leishmania infectionAnh Thu Nguyen Hoang, Hao Liu, Julius Juaréz, et al.
Trends in Parasitology|March 2, 2026
Breaking the deadlock in antigen discovery for Leishmania vaccinesWim Adriaensen, Nicky de Vrij, Thao-Thy Pham, et al.
Frontiers in Immunology|January 30, 2018
Immunomodulatory Therapy of Visceral Leishmaniasis in Human Immunodeficiency Virus-Coinfected PatientsWim Adriaensen, Thomas P C Dorlo, Guido Vanham, et al.
Frontiers in Immunology|September 3, 2019
IL-4 Mediated Resistance of BALB/c Mice to Visceral Leishmaniasis Is Independent of IL-4Rα Signaling via T CellsEmma McFarlane, Thabang Mokgethi, Paul M Kaye, et al.
The Lancet. Respiratory Medicine|December 6, 2021
Post-mortem lung tissue: the fossil record of the pathophysiology and immunopathology of severe COVID-19Luke Milross, Joaquim Majo, Nigel Cooper, et al.
Archives of Toxicology|December 22, 2016
In vivo imaging of systemic transport and elimination of xenobiotics and endogenous molecules in miceRaymond Reif, Ahmed Ghallab, Lynette Beattie, et al.
Parasites & Vectors|January 10, 2020
Leishmania braziliensis prostaglandin F<sub>2α</sub> synthase impacts host infectionEliza Vanessa Carneiro Alves-Ferreira, Tiago Rodrigues Ferreira, Pegine Walrad, et al.
Plos Neglected Tropical Diseases|July 3, 2020
The potential impact of human visceral leishmaniasis vaccines on population incidenceEpke A Le Rutte, Luc E Coffeng, Stefano Malvolti, et al.
Vaccine|November 11, 2023
Vaccine value profile for leishmaniasisPaul M Kaye, Greg Matlashewski, Sakshi Mohan, et al.
The American Journal of Pathology|December 8, 2004
Distinct roles for lymphotoxin-alpha and tumor necrosis factor in the control of Leishmania donovani infectionChristian R Engwerda, Manabu Ato, Simona Stäger, et al.
Pageof 14